Case ID: M25-130L

Published: 2026-03-05 11:23:26

Last Updated: 1772709806


Inventor(s)

Mark Knappenberger
Karen Anderson

Technology categories

Applied TechnologiesBioanalytical Assays, Chemistries & DevicesDiagnostic Assays/DevicesLife Science (All LS Techs)Point of Care

Licensing Contacts

Jovan Heusser
Director of Licensing and Business Development
[email protected]

Rapid, Sensitive, LAMP Assay for Monkeypox Virus Clade Differentiation

Invention Description
Orthopox monkeypox (MPXV) has recently emerged as a global viral threat with two distinct clades identified as endemic pathogens. It is estimated that 70% of the world’s population is vulnerable to infection by members of orthopoxviridae.  Rapid identification of MPXV clades is critical, as Clade I infections are more clinically severe than Clade II. Current MPXV differentiation diagnostics either cannot distinguish between the different clades or require additional post-amplification steps, increasing time, cost, and complexity. These limitations reduce the effectiveness of point-of-care testing, especially in outbreak prone and low-resource settings.
 
Researchers at Arizona State University have developed a rapid, sensitive, and specific loop-mediated isothermal amplification (LAMP) assay with specialized primer sets for detecting and differentiating Monkeypox virus clades and Orthopoxvirus lineages. This assay utilizes a single, one-tube amplification reaction with no downstream processing and can be carried out in less than one hour. Designed for point-of-care use, it works directly on crude samples such as skin lesions and bodily fluids, requiring minimal equipment and no sample purification. Additionally, it can be seamlessly integrated into portable microfluidic cartridges for field diagnostics, providing rapid and reliable results validated against conventional qPCR benchmarks.
 
This cost-effective assay represents a novel method for differentiating between highly homologous viral variants for viral surveillance of pathogens in PoC settings.
 
Potential Applications
  • Rapid, PoC diagnostics during MPXV outbreaks
  • Outbreak response and public health surveillance in low-resource or remote areas
  • Clinical diagnostics to guide patient management based on viral clade severity
  • Extension to detection of other pathogens featuring genomic insertions or deletions
  • Wildlife and zoonotic disease monitoring
  • Integration into portable diagnostic platforms for on-site testing
Benefits and Advantages
  • Rapid one-tube reaction requiring minimal sample processing
  • High specificity and sensitivity with negligible false positives
  • Direct use on crude patient lesion samples, eliminating complex preparation
  • Capable of differentiating closely related viral clades
  • Able to differentiate MPXV clades and detect broad Orthopoxvirus lineages
  • Three validated primer sets ensure high specificity while reducing non-specific amplification
  • Low limit of detection enables early and accurate diagnosis
  • Isothermal amplification eliminates the need for complex thermal cyclers
  • Compatible with portable microfluidic devices for field deployment